IFITM2 and breast ductal adenocarcinoma: A non-significant difference in IFITM2 expression between the tumor tissue and normal adjacent tissues was observed, which was correlated with immunochemical studies that showed negative in normal tissue compared to ductal carcinoma, where it was positive.